133 related articles for article (PubMed ID: 8678023)
1. Chemotherapy in stage II/Duke's B2 colon cancer: tolerable but necessary?
Brown TD
Am J Gastroenterol; 1996 Jul; 91(7):1466-7. PubMed ID: 8678023
[No Abstract] [Full Text] [Related]
2. Optimal duration of fluorouracil plus levamisole colon cancer surgical adjuvant therapy.
O'Connell MJ; Kahn MJ; Erlichman C; Goldberg RM; Shepherd LE
J Clin Oncol; 1996 Oct; 14(10):2887. PubMed ID: 8874353
[No Abstract] [Full Text] [Related]
3. Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer.
Focan C; Bury J; Beauduin M; Herman ML; Vindevoghel A; Lecomte M; Brohée D; Canon JL; Focan-Henrard D;
Anticancer Res; 2000; 20(6C):4665-72. PubMed ID: 11205198
[TBL] [Abstract][Full Text] [Related]
4. [Adjuvant treatment for colon carcinoma. Results and perspectives].
Wein A; Riedel C; Lehnert T; Wakker R; Reingruber B; Teichmann W; Kohnen R; Herfarth C; Hohenberger W; Hahn EG
Dtsch Med Wochenschr; 1998 May; 123(21):674-80. PubMed ID: 9638096
[No Abstract] [Full Text] [Related]
5. [The importance of adjuvant chemotherapy in the treatment of colonic carcinoma: SAKK Study 40/93 (Swiss Work Group for Clinical Cancer Research)].
Hess P; Heinicke JM; Laffer UT
Rev Med Suisse Romande; 1997 Feb; 117(2):151-4. PubMed ID: 9173508
[No Abstract] [Full Text] [Related]
6. Adjuvant therapy of colorectal cancer.
Kemeny N; Saltz L; Cohen A
Surg Oncol Clin N Am; 1997 Oct; 6(4):699-722. PubMed ID: 9309089
[TBL] [Abstract][Full Text] [Related]
7. Immunological alterations induced by adjuvant treatment of postoperative colon carcinoma Duke's B or C with levamisole in combination with 5-FU.
De Brabander M; Vandebroek J; Wassenaar H; De Crée J; Baisier A; Demoen B; De Ridder R; Jagers E; Roels V; Vogels O
Anticancer Res; 1995; 15(5B):2271-7. PubMed ID: 8572636
[TBL] [Abstract][Full Text] [Related]
8. [Adjuvant chemotherapy improves chances of survival in curative surgery of colon cancer, Dukes' stage C].
Porschen R; Stremmel W
Z Gastroenterol; 1990 Jul; 28(7):375-6. PubMed ID: 2238769
[No Abstract] [Full Text] [Related]
9. [Adjuvant treatment in operable colonic and rectal cancer. A new possibility].
Tveit KM
Tidsskr Nor Laegeforen; 1997 Aug; 117(20):2991-2. PubMed ID: 9340862
[No Abstract] [Full Text] [Related]
10. [Should adjuvant chemotherapy be also used in Dukes stage B2 colon cancer?].
Porschen R
Z Gastroenterol; 1996 Sep; 34(9):549-51. PubMed ID: 8975491
[No Abstract] [Full Text] [Related]
11. Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III.
Taal BG; Van Tinteren H; Zoetmulder FA;
Br J Cancer; 2001 Nov; 85(10):1437-43. PubMed ID: 11720425
[TBL] [Abstract][Full Text] [Related]
12. Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089.
Haller DG; Catalano PJ; Macdonald JS; O'Rourke MA; Frontiera MS; Jackson DV; Mayer RJ
J Clin Oncol; 2005 Dec; 23(34):8671-8. PubMed ID: 16314627
[TBL] [Abstract][Full Text] [Related]
13. Progress in the adjuvant treatment of colon cancer: has it influenced clinical practice?
Van Cutsem E; Costa F
JAMA; 2005 Dec; 294(21):2758-60. PubMed ID: 16333012
[No Abstract] [Full Text] [Related]
14. [Treatment of colonic cancer and follow up].
Belmonte-Montes C; Cosme-Reyes C
Rev Gastroenterol Mex; 2007 Nov; 72 Suppl 2():122-5. PubMed ID: 18277499
[No Abstract] [Full Text] [Related]
15. Adjuvant therapy for colon cancer in the new millenium.
Rao S; Cunningham D
Scand J Surg; 2003; 92(1):57-64. PubMed ID: 12705552
[TBL] [Abstract][Full Text] [Related]
16. [Adjuvant therapy for colon cancer].
Moiseenko VM; Orlova RV
Vopr Onkol; 1998; 44(6):741-5. PubMed ID: 10087982
[No Abstract] [Full Text] [Related]
17. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?
Gill S; Loprinzi CL; Sargent DJ; Thomé SD; Alberts SR; Haller DG; Benedetti J; Francini G; Shepherd LE; Francois Seitz J; Labianca R; Chen W; Cha SS; Heldebrant MP; Goldberg RM
J Clin Oncol; 2004 May; 22(10):1797-806. PubMed ID: 15067028
[TBL] [Abstract][Full Text] [Related]
18. Multifocal inflammatory leukoencephalopathy after fluorouracil and levamisole therapy for colon cancer.
Murray CL; Ford WJ; Swenson KK; Heros D; Sperduto PW
AJNR Am J Neuroradiol; 1997 Sep; 18(8):1591-2. PubMed ID: 9296206
[No Abstract] [Full Text] [Related]
19. Progress and challenges in the adjuvant treatment of stage II and III colon cancers.
Chua YJ; Zalcberg JR
Expert Rev Anticancer Ther; 2008 Apr; 8(4):595-604. PubMed ID: 18402526
[TBL] [Abstract][Full Text] [Related]
20. Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group.
Dahl O; Fluge Ø; Carlsen E; Wiig JN; Myrvold HE; Vonen B; Podhorny N; Bjerkeset O; Eide TJ; Halvorsen TB; Tveit KM;
Acta Oncol; 2009; 48(3):368-76. PubMed ID: 19242829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
